These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37837881)

  • 1. Single-cell sequencing in pancreatic cancer research: A deeper understanding of heterogeneity and therapy.
    Liu Z; Zhang Y; Wu C
    Biomed Pharmacother; 2023 Dec; 168():115664. PubMed ID: 37837881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
    Lin W; Noel P; Borazanci EH; Lee J; Amini A; Han IW; Heo JS; Jameson GS; Fraser C; Steinbach M; Woo Y; Fong Y; Cridebring D; Von Hoff DD; Park JO; Han H
    Genome Med; 2020 Sep; 12(1):80. PubMed ID: 32988401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
    Chandana S; Babiker HM; Mahadevan D
    Expert Opin Investig Drugs; 2019 Feb; 28(2):161-177. PubMed ID: 30539678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy.
    Bärthel S; Falcomatà C; Rad R; Theis FJ; Saur D
    Nat Cancer; 2023 Apr; 4(4):454-467. PubMed ID: 36959420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects.
    Polani F; Grierson PM; Lim KH
    World J Gastroenterol; 2021 May; 27(18):2105-2121. PubMed ID: 34025067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of PDAC subtype heterogeneity and therapy response.
    Espinet E; Klein L; Puré E; Singh SK
    Trends Cancer; 2022 Dec; 8(12):1060-1071. PubMed ID: 36117109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Medicine and Pancreatic Cancer.
    George B
    Surg Oncol Clin N Am; 2021 Oct; 30(4):693-708. PubMed ID: 34511190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
    Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
    EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
    Huang H; Brekken RA
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell sequencing reveals heterogeneity between pancreatic adenosquamous carcinoma and pancreatic ductal adenocarcinoma with prognostic value.
    Zhang D; Wu S; Pan S; Wang M; Wang Z; He Z; Zhang G; Cui F; Song Y; Li W; Shi X; Huang H; Xu H
    Front Immunol; 2022; 13():972298. PubMed ID: 36052088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil in the Pancreatic Tumor Microenvironment.
    Jin L; Kim HS; Shi J
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of pancreatic cancer therapy resistance by chemokines.
    Gautam SK; Basu S; Aithal A; Dwivedi NV; Gulati M; Jain M
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):69-80. PubMed ID: 36064086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance.
    Sherman MH; Beatty GL
    Annu Rev Pathol; 2023 Jan; 18():123-148. PubMed ID: 36130070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic resistance of pancreatic cancer: Roadmap to its reversal.
    Yu S; Zhang C; Xie KP
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188461. PubMed ID: 33157162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma.
    Wang D; Cui SP; Chen Q; Ren ZY; Lyu SC; Zhao X; Lang R
    BMC Cancer; 2023 Jun; 23(1):601. PubMed ID: 37386391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
    Peran I; Dakshanamurthy S; McCoy MD; Mavropoulos A; Allo B; Sebastian A; Hum NR; Sprague SC; Martin KA; Pishvaian MJ; Vietsch EE; Wellstein A; Atkins MB; Weiner LM; Quong AA; Loots GG; Yoo SS; Assefnia S; Byers SW
    Gastroenterology; 2021 Mar; 160(4):1359-1372.e13. PubMed ID: 33307028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer stem cells: A state or an entity?
    Hermann PC; Sainz B
    Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15
    Dominguez CX; Müller S; Keerthivasan S; Koeppen H; Hung J; Gierke S; Breart B; Foreman O; Bainbridge TW; Castiglioni A; Senbabaoglu Y; Modrusan Z; Liang Y; Junttila MR; Klijn C; Bourgon R; Turley SJ
    Cancer Discov; 2020 Feb; 10(2):232-253. PubMed ID: 31699795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.